Personalizing the Treatment of Recurrent/Metastatic HNSCC: A Multifactorial Path
Host: Barbara Burtness, MD
\n\n Guest: Nabil F. Saba, MD, FACP
\n\n\n \n
KEYNOTE-048 has opened new vistas to managing patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Nonetheless, uncertainties remain in matching the correct patient with the correct strategy. Join Drs. Barbara Burtness and Nabil Saba as they parse the key trials and offer insight into building treatment algorithms designed to optimize outcomes for your patients with R/M HNSCC.